Our previous study on the secondary metabolites of the basidiomycete Boreostereum vibrans resulted in the isolation of a series of vibralactone-related compounds. 1, 2) The main constituent vibralactone showed inhibitory activity against pancreatic lipase with an IC 50 value of 0.4 mg/ml. Our continuing investigation on the chemical constituents of this fungus has led to the isolation of three further new metabolites, vibralactones D-F (1-3). Vibralactone D (1) showed inhibitory activities against two isozymes of 11b-hydroxysteroid dehydrogenases (11b-HSD1 and 11b-HSD2) that catalyze the interconversion of active cortisol and inactive cortisone.
Results and Discussion
Vibralactone D (1) was obtained as colorless crystal. Its molecular formula was established to be C 12 H 18 O 3 according to the pseudomolecular molecular ion at m/z 211.1330 [MϩH] ϩ using high-resolution electrospray ionization mass spectrometry (HR-ESI-MS). The IR spectrum showed the presence of hydroxy (3504 cm
Ϫ1
) and carbonyl (1714 cm Ϫ1 ) groups. 13 C-NMR and distortionless enhancement by polarization transfer (DEPT) data (Table 1) revealed 12 carbon signals assigned to one carbonyl, one trisubstituted double bond, one quaternary carbon, two methines (one oxygenated), four methylenes (one oxygenated), and two methyls. The signals at d C 17.8 (q, C-11), 25.9 (q, C-12), 30.5 (t, C-8), 119.4 (d, C-9), 135.0 (s, C-10), d H 1.60 (s, H-11), 1.68 (s, H-12), and 5.15 (dd, Jϭ7.8, 6.9 Hz, H-9) indicated the presence of an isoprenyl group. In the heteronuclear multiple bond connectivity (HMBC) spectrum of 1 (Fig. 1) , the correlations of H-8/C-2, -5, and C-7; H-2/C-4, -5, C-13; H-3/C-1, -5; H-4/C-1, -13; H-5/C-3, -7, -8 and H-13/C-2, -4 were observed. The structure of 1 was confirmed in an X-ray experiment (Fig. 2) . The absolute stereochemistry of 1 was determined using a modified Mosher's method.
3) The (S)-and (R)-alpha-methoxy-alpha-(trifluoromethyl)phenylacetic acid (MTPA) esters of 1 were prepared. Positive Dd (d S Ϫd R ) values (Fig. 3) were observed for H-5 (ϩ0.10), H-8 (ϩ0.09, ϩ0.05), H-9 (ϩ0.04), H-11 (ϩ0.05), and H-12 (ϩ0.01), while negative Dd values were observed for H-3 (Ϫ0.04), H-4 (Ϫ0.10, Ϫ0.18), and H-13 (Ϫ0.05, Ϫ0.12). These data indicate an S configuration for C-5 and therefore, an absolute configuration of 1R, 3S, 5S for vibralactone D (1). H COSY) spectrum.
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C, 1 H long-range couplings ( 3 J) observed in the HMBC experiments gave the following correlations from H-2 to C-4, C-5, and C-13, from H-9 to C-1, C-11, and C-12, from H-5 to C-2, C-3, C-7, and C-8, from H-13 to C-2 and C-4, from H-4 to C-2, from H-8 to C-2, C-5, and C-10, from H-12 to C-9 and C-11, and from H-11 to C-9 and C-12. The data of 2 were similar to those of vibralactone, 1) except that 2 had one degree of unsaturation less and chemical shifts at C-1 (Dd Ϫ9.1), C-2 (Dd ϩ5.2), C-4 (Dd ϩ4.1), C-7 (Dd ϩ4.3), and C-8 (Dd ϩ8.5) as compared with those of vibralactone. By combining all this evidences and data, we were able to assign the planar structure of 2 as shown in Fig. 4 , revealing the presence of hydroxy and carbonyl groups. The 13 C-NMR and DEPT spectra (Table 1) (Fig. 3) revealed the absolute configuration at C-5 to be S. This suggested that H-5 took the b orientation. The cross peaks between H-5 and H-8 in the ROESY spectrum suggested that the isoprenyl group also took the b orientation. Thus the absolute configuration of vibralactone E (2) was elucidated to be 1R, 5S. In the same manner, the absolute configuration of 3 at C-5 was assigned as R, indicating that H-5 was a oriented. No NOE correlation peak was observed between H-5 and H-8, indicating that the isoprenyl group was b oriented. From the data above, the 1R, 5R configuration was assigned to vibralactone F (3). A possible biogenetic pathway of vibralactones A-F is proposed (Chart 1).
We investigated the inhibitory effects of the compounds on human and mouse 11b-HSD1 and 11b-HSD2. All experiments were done in triplicate with glycyrrhizininc acid as a positive control. IC 50 (ϮS.D., nϭ3) values were calculated using Prism Version 4 (GraphPad Software, San Diego, CA, U.S.A.). IC 50 values of glycyrrhizininc acid (positive control) are 29.5, 18.6, and 0.71 nM for mouse 11b-HSD1, human 11b-HSD1, and human 11b-HSD2, respectively. Vibralactone D (1) showed inhibitory activities against 11b-HSD1 (human IC 50 ϭ85.7 mM; mouse IC 50 ϭ295.2 mM) and 11b-HSD2 (human IC 50 ϭ87.1 mM). Vibralactones E and F (2 and   114 Vol. 58, No. 1 3) showed weak activity (43.6% and 31.2% inhibition at 150 mg/ml) against human 11b-HSD1 and (37.7% and 24.8% inhibition at 150 mg/ml) mouse 11b-HSD1.
Experimental
General Experimental Procedures Melting points were measured on an XRC-1 apparatus (Sichuan University, Sichuan, P. R. China). Optical rotations were obtained with a Horiba SEPA-300 digital polarimeter. IR spectra were recorded on a Bruker Tensor-27 spectrometer. NMR spectra were recorded on Bruker AV-400 and DRX-500 instruments. Mass spectra were recorded on a VG Autospec-3000 mass spectrometer and an API QSTAR pulsar 1 spectrometer. Column chromatography and TLC were carried out on Silica gel (200-300 mesh) and precoated silica gel GF254 plates (Qingdao Marine Chemical Inc., P. R. China). Biological Testing The inhibition activity of compounds on human or mouse 11b-HSD1 and 11b-HSD2 enzymatic activities was determined in the scintillation proximity assay (SPA) using microsomes containing 11b-HSD1 or 11b-HSD2 as described in previous studies. 4) Briefly, the fulllength cDNAs of human or murine 11b-HSD1 and 11b-HSD2 were isolated from the cDNA libraries provided by the NIH Mammalian Gene Collection and cloned into a pcDNA3 expression vector. HEK-293 cells were transfected with the pcDNA3-derived expression plasmid and selected after cultivation in the presence of 700 mg/ml of G418. The microsomal fraction overexpressing 11b-HSD1 or 11b-HSD2 was prepared from the HEK-293 cells stably transfected with either 11b-HSD1 or 11b-HSD2 and used as the enzyme source for Scintillation Proximity Assay (SPA MTPA Esters of Compounds 1-3 A mixture of 1 (4.3 mg), (S)-MTPA (39.3 mg), 1,3-dicyclohexylcarbodiimde (DCC, 39.7 mg), and 4-(dimethylamino)pyridine (DMAP, 7.0 mg) was dissolved in 3 ml of dry CH 2 Cl 2 and stirred at room temperature for 10 h. The reaction mixture was filtered, and the concentrated filtrate was chromatographed over silica gel (eluted with CHCl 3 ) to yield the purified Mosher ester of 1a (5.0 mg). The methyl esters after reaction with trimethylsilyldiazomethane (TMSCHN 2 ) were prepared from 2 and 3 using a procedure published in the literature.
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5) The other MTPA esters were prepared in the same manner as 1a and characterized by measurement of their 1 
